Post Tue Oct 04, 2016 3:09 pm

2016-Saenz et al-Leukemia

"BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells"
Saenz D T; Fiskus W; Manshouri T; Krieger S; Sun B; Mill C P; DiNardo C; Pemmaraju N; Kadia T; Verstovsek S; Bhalla K N; Rajapakshe K; Coarfa C; Parmar S; Sharma S; Qiu P
Leukemia, 2016
http://dx.doi.org/10.1038/leu.2016.260